magnolol has been researched along with Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, SC; Huang, CH; Huang, PC; Huang, PH; Lai, CC; Tang, CY; Tseng, KW; Yang, AH | 2 |
| Gu, M; Guo, W; Huang, L; Liu, Y; Sun, H; Wang, N; Wu, Y; Xu, L; Yang, Y | 1 |
3 other study(ies) available for magnolol and Ischemia
| Article | Year |
|---|---|
Magnolol reduces myocardial injury induced by renal ischemia and reperfusion.
Topics: Animals; Apoptosis; Biphenyl Compounds; Interleukin-10; Interleukin-6; Ischemia; Lignans; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Stroke Volume; Troponin I; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2022 |
Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Eosine Yellowish-(YS); Glaucoma; Hematoxylin; Inflammation; Ischemia; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Reperfusion Injury; Retina | 2022 |
Magnolol Reduces Renal Ischemia and Reperfusion Injury via Inhibition of Apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Infusions, Intravenous; Interleukin-10; Interleukin-1beta; Interleukin-6; Ischemia; JNK Mitogen-Activated Protein Kinases; Kidney; Lignans; Male; Mitogen-Activated Protein Kinase 3; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |